Skip to main content
See every side of every news story
Published loading...Updated

CAR T Therapy Induces Remission in Multiple Autoimmune Diseases

The experimental treatment ended daily blood transfusions and drove complete remission within 25 days, researchers said.

  • A 47-year-old woman in Germany has entered complete remission after receiving experimental CAR-T cell therapy for three autoimmune diseases—AIHA, APLAS, and ITP—doctors at University Hospital Erlangen report.
  • Her condition had become life-threatening, as rogue B cells attacked her tissues, requiring daily blood transfusions and multiple failed medications over a decade.
  • Hematologist Fabian Müller isolated the patient's T cells, engineering them to target CD19 proteins on B cells before reinfusing them to eliminate the rogue cells.
  • Symptoms improved within weeks; the patient no longer requires transfusions and has returned to an almost normal life, even working at the clinic where she was treated.
  • Müller suggests that intervening earlier with CAR-T therapy could prevent long-term organ damage for other patients with severe autoimmune conditions, avoiding complications from years of ineffective treatments.
Insights by Ground AI

17 Articles

Lean Right

Suddenly, scientists were able to use innovative cell therapy called CAR-T Cell, to treat a patient with three different and potentially fatal autoimmune diseases, which had been resistant to treatment for years. The details of the case were published on this Thursday, as an article in the scientific magazine Med, of Cell Press. How to prevent black clothes from disappearing? Configure these practices to care for the pieces Bola pré front! The o…

·Brazil
Read Full Article
Center

For the first time, scientists at Erlangen University Hospital in Germany have used CAR-T cell therapy to treat a patient with three life-threatening autoimmune diseases who had resisted years of treatment. The patient, who previously required daily blood transfusions, has been in remission for one year without any additional treatment since CAR-T therapy began. The case report, published in Cell Press’s Med magazine, suggests that CAR-T therapi…

·Madrid, Spain
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 60% of the sources are Center
60% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Nature broke the news in United Kingdom on Thursday, April 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal